Tumor necrosis factor gene polymorphisms and clearance or progression of hepatitis B virus infection

Liver International

Volumn 25, Issue 6, 2005, Pages 1175-1181

  Niro, Grazia Anna ^a   Fontana, Rosanna ^a   Gioffreda, Domenica ^a   Valvano, Maria Rosa ^a   Lacobellis, Angelo ^a   Facciorusso, Domenico ^a   Andriulli, Angelo ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

Chronic hepatitis; Cirrhosis; Haplotypes; HBV; HCC; TNF polymorphisms

Indexed keywords

GENOMIC DNA; HEPATITIS B SURFACE ANTIGEN; TUMOR NECROSIS FACTOR;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENOTYPE; HAPLOTYPE; HEPATITIS B; HUMAN; ITALY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; SEROPREVALENCE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VIRUS CARRIER; VIRUS TRANSMISSION;

CARRIER STATE; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HEPATITIS B ANTIBODIES; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROGNOSIS; PROMOTER REGIONS (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

EID: 28944453775     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2005.01166.x     Document Type: Article

References (27)

1. Hyams K C. Risks of chronicity following acute hepatitis B virus infection review. Clin Infect Dis 1995; 20: 992-1000.
2. Kakimi K, Guidotti L G, Koezuka Y, Chisari F V. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 2000; 192: 921-30.
3. Penna A, Del Prete G, Cavalli G, Bertoletti A, D'Elios M M, Sorrentino R, et al. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B. Hepatology 1997; 25: 1022-7.
4. Guidotti L G, Chisari F V. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001; 19: 65-91.
5. Brunetto M R, Oliveri F, Coco B, Leandro G, Colombatto P, Gorin J M, et al. Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study. J Hepatol 2002; 36: 263-70.
6. Fattovich G, Brollo L, Giustina G, Noventa F, Pontisso P, Alberti A, et al. Natural history and prognostic factors of chronic hepatitis type B. Gut 1991; 32: 294-8.
7. Fattovich G, Pantalena M, Zagni I, Realdi G, Schalm S W, Christensen E, et al. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients. Am J Gastroenterol 2002; 97: 2886-95.
8. Romero R, Lavine J E. Cytokine inhibition of the hepatitis B virus core promoter. Hepatology 1996; 23: 17-23.
9. Rossol S, Marinos G, Carucci P, Singer M V, Williams R, Naoumov N V. Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B. J Clin Invest 1997; 99: 3025-33.
10. Ruddle N H. Tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta). Curr Opin Immunol 1992; 4: 327-32.
11. Danis V A, Millington M, Hyland V J, Grennan D. Cytokine production by normal human monocytes: intersubjects variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 1995; 99: 303-10.
12. Ugliarolo A M, Turbay D, Pesavento P A, Delgado J C, McKenzie F E, Gribbon J G, et al. Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter. Tissue Antigens 1998; 52: 359-67.
13. D'Alfonso S, Richiardi P M. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 1994; 39: 150-4.
14. Miyazoe S, Hamasaki K, Nakata K, Kajiya Y, Kitajima K, Nakao K, et al. Influence of Interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus. Am J Gastroenterol 2002; 97: 2086-92.
15. Hohler T, Kruger A, Gerken G, Schneider P M, Meyer zum Buschenefelde K H, Rittner C. A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clin Exp Immunol 1998; 111: 579-582.
16. Kim Y J, Lee H-S, Yoon J-H. Association of TNF-α promoter polymorphism with the clearance of hepatitis B virus infection. Hum Mol Genet 2003; 12: 2541-6.
17. Penna A, Chisari F V, Bertoletti A, Missale G, Fowler P, Giuberti T, et al. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. J Exp Med 1991; 174: 1565-70.
18. Tsui L V, Guidotti L G, Ishikawa T, Chisari F V Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes. Proc Natl Acad Sci USA 1995; 92: 12398-402.
19. Esteve M, Saro C, Gonzalez-Huix F, Suarez F, Forne M, Viver J M. Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis. Gut 2004; 53: 1363-5.
20. Reynard M P, Turner D, Navarrete C V. Allele frequencies of polymorphisms of the tumor necrosis factor-α, interleukin-10, interferon-γ and interleukin-2 in a North European Caucasoid group from the UK. Eur J Immunogenet 2000; 27: 241-9.
21. Poli F, Nocco A, Berra S, Scalamogna M, Taioli E, Longhi E, et al. Allele frequencies of polymorphisms of TNFA, IL-6, IL-10 and IFNG in an Italian Caucasian population. Eur J Immunogenet 2002; 29: 237-40.
22. Conway D J, Holland M J, Bailey R L, Campbell A E, Mahdi O S, Jennings R, et al. Scarring trachoma is associated with polymorphism in the tumor necrosis alpha (TNF-alpha) gene promoter and with elevated TNF-alpha in tear fluid. Infect Immun 1997; 65: 1003-6.
23. Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, Kato H, et al. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF) alpha gene in Japanese. Tissue Antigens 1998; 51: 605-12.
24. Ben-Ari Z, Mor E, Papo O, Kfir B, Sulkes J, Tambur A R, et al. Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterol 2002; 97:2086-92.
25. Wilson A G, Symons J A, McDowell T L, McDevitt H O, Duff G W. Effects of polymorphism in the human necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195-9.
26. Wilson A G, De Vries N, Pociot F, Di Giovine F S, Van der Putte L B, Duff G W. An allelic polymorphism within the human tumor necrosis factor a promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993; 177: 557-60.
27. Ahn S H, Han K H, Park J Y, Lee C K, Kang S W, Chon C Y, et al. Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatology 2000; 31: 1371-3.